Why is Eiko Lifescience falling/rising?

As of 09-Jul, Eiko Lifesciences Ltd is currently priced at 59.50, reflecting a decrease of 0.89, or 1.47%. The stock has shown a strong performance over the past year, generating a return of 17.82%, significantly outperforming the market benchmark, which returned only 1.43%. However, today's performance indicates a decline, as it underperformed its sector by 1.85%. Additionally, while the stock is trading above its moving averages across various time frames, there has been a notable drop in investor participation, with delivery volume falling by 84.82% compared to the 5-day average. The increase in promoter stake by 4.96% suggests confidence in the company's future, but the weak long-term fundamentals, indicated by a low return on equity of 2.82% and flat quarterly results, raise concerns about its valuation.
In the broader market context, Eiko Lifesciences has outperformed the benchmark in the short term, with a 2.59% gain over the past week compared to the Sensex's modest increase of 0.15%. Despite this short-term outperformance, the stock's year-to-date performance shows a decline of 5.16%, contrasting with the Sensex's gain of 6.91%. The combination of strong past returns and rising promoter confidence is overshadowed by the recent drop in trading volume and concerns over fundamental weaknesses, contributing to the stock's current downward movement.